A safe, cost-effective, non-invasive, accurate screening for Cancer

Developed in the late 1930's by the renowned oncologist, the late Dr. Manuel D. Navarro, the test detects the presence of HCG* in urine. It indicates the presence of cancer cells even before signs or symptoms develop. Dr. Navarro found HCG to be elevated in all types of cancers.
The test is based on a theory proposed by Dr. Howard Beard and other researchers who contend that cancer is related to a misplaced trophoblast cell that becomes malignant in a manner similar to pregnancy in that they both secrete HCG.

As a consequence, a measure of the amount of HCG found in the blood or urine is also a measure of the degree of malignancy. The higher the number, the greater the severity of the cancer.

Urine, as opposed to blood or serum, is the preferred specimen for the test. In 1980, Papapetrou and co-authors reported the correctness of the urine specimen to be used in HCG Immunoassay. In 32 proven cancer cases, the immunoassay test gave 31 positive results using urine while only 12 positive results were reported using blood. HCG has been found to undergo glycosylation in the liver as it travels in the hepatic circulation. Thus, the HCG molecule cannot be detected. The molecule does not undergo this process in the kidney and therefore the molecule remains intact in the urine.

The test detects the presence of brain cancer as early as 29 months before symptoms appear; 27 months for fibrosarcoma of the abdomen; 24 months for skin cancer; 12 months for cancer of the bones (metastasis from breast cancer extirpated 2 years earlier).

Currently, many cancer patients take advantage of the diagnostic accuracy of this test as an indicator of the effectiveness of their specific mode of therapy. Patients follow a simple direction for preparing a dry extract from the urine sample. The powdery extract is mailed to the Navarro Medical Clinic where the HCG testing is performed.

http://www.vitaminlady.com/articles/navarro-urine-test.htm

r

r

Blood test finds breast cancer at its earliest stage

A new blood test that detects breast cancer at its earliest stage could become a vital weapon in fighting the disease.

Scientists found the test could pinpoint cancer long before it would show up using other methods.
They believe it could be adapted to identify ovarian and prostate cancers as well.

Trial results showed it was up to 1,000 times more sensitive than existing tests.
The results could have far-reaching implications for diagnosis of the disease, which claims up to 400,000 lives a year worldwide.

Breast cancer is the most common female cancer, with 1.1million new cases each year.
In Britain, more than 40,000 women are diagnosed annually, with more than 12,400 deaths.
Doctors currently use a combination of breast examination, imaging with mammography and ultrasonography, and biopsy to diagnose the condition.

But researchers recently claimed such scans could actually trigger the disease in some women.
Cancer specialists found radiation from the X-rays leaves those with a family history of breast cancer more than 50 per cent more likely to develop it.

They said the risk was highest for young women and those repeatedly given X-rays.
This means a more effective screening method is needed, especially for the rarer cases involving younger women. The new blood test offers the best hope.

It works by detecting subtle changes in proteins in the bloodstream, caused when the immune system starts to fight a cancer.

The test may also help identify whether a tumour is malignant or benign, ensuring the best treatment can be quickly selected. Early detection of cancer gives the best chance of effective treatment. The five-year survival rate can be as high as 97 per cent if the disease has not spread.

Professor Jasminka Godovac-Zimmerman, from University College London, reports the findings in the Journal of Proteome Research today.

She led the group which included scientists from the Universities of Pennsylvania and Pittsburgh and the U.S.company BioTraces Inc, based in Herndon, Virginia.

"Our pilot studies show that using blood samples, breast cancer and several other types of epithelial cancers (ovarian, prostate, melanoma) can be detected with much better sensitivity and specificity," she said.

She said this may allow new, less intrusive, safer and much less expensive approaches for the early diagnosis of cancer.

It would also help in distinguishing malignant and benign tumours and in monitoring cancer therapy.

Stephen Duffy, Cancer Research UK's professor of screening, said further trials are needed before the test can be used by doctors.

http://www.dailymail.co.uk/health/
article-399033/Blood-test-finds-breast-cancer-earliest-stage.html
r
The More You Know ...
r

The Myth of Early Cancer Detection

"It matters not wether you detect cancer with any test because the treatments offered by allopathic medicine is only palliative. They do not address the cause of the disease. Amputation of the appendages is NEVER REQUIRED but continues to be practiced because surgical remedies are incredibly lucrative.

Tumors dissolve on their own if the necessary digestive enzymes are permitted to perform their primary function without the distraction of having to divert their powers for the emaciation of excessive animal proteins.

Cancer, like diabetes, is a disease of the fork and spoon. People don't 'catch' this disease, they earn it through inadequate nutrition and improper hygiene. Early detection is moot! Absolutely no one needs to die from this totally curable disease!"

http://www.newmediaexplorer.org/chris/
2006/08/15/the_myth_of_early_cancer_detection.htm
r

Dr. William Amalu on ABC News on thermography

Thermography Should be Offered Everywhere